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Study of Parents and Children
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George Davey Smith1,2 and Sarah J Lewis1Abstract
Background: In observational epidemiological studies type 2 diabetes (T2D) and both low and high plasma
concentrations of fasting glucose have been found to be associated with lower cognitive performance. These
associations could be explained by confounding.
Methods: In this study we looked at the association between genetic variants, known to be robustly associated
with fasting glucose and T2D risk, in the mother and her offspring to determine whether there is likely to be a
causal link between early life exposure to glucose and child’s intelligence quotient (IQ) scores in the Avon
Longitudinal Study of Parents and Children (ALSPAC) cohort. We generated a fasting glucose (FGGRS) and a T2D
(T2DGRS) genetic risk score and used them in a Mendelian randomization approach.
Results: We found a strong correlation between the FGGRS and fasting glucose plasma measurements that were
available for a subset of children, but no association of either the maternal or the offspring FGGRS with child’s IQ
was observed. In contrast, the maternal T2DGRS was positively associated with offspring IQ.
Conclusions: Maternal and offspring genetic variants which are associated with glucose levels are not associated
with offspring IQ, suggesting that there is unlikely to be a causal link between glucose exposure in utero and IQ in
childhood. Further exploration in even larger cohorts is required to exclude the possibility that our null findings
were due to a lack of statistical power.
Keywords: Mendelian randomization, Fasting glucose, Type 2 diabetes, IQ, ALSPACBackground
Brain development occurs most rapidly in utero and in
young children up to 2–3 years of age, although it con-
tinues well into adulthood [1]. The rapid growth of the
foetal and infant brain places an exceptionally high demand
on the supply of nutrients from the diet, as adequate levels
of certain nutrients are required for cell growth, the syn-
thesis of new tissues, synapse formation and myelination* Correspondence: C.Bonilla@bristol.ac.uk
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reproduction in any medium, provided the or[2]. Glucose is the brain’s main energy source and is trans-
ported across the blood–brain barrier, as neurons are un-
able to store or synthesize it [3,4]. During pregnancy
glucose crosses the placenta to meet the energy require-
ments of the developing foetus since there is almost no
foetal gluconeogenesis [5]. High maternal plasma glucose
levels, such as those experienced by mothers with poorly
controlled diabetes, mean that a greater amount of glucose
is transferred to the foetus, which in turn triggers an
increased production of foetal insulin and promotes exces-
sive growth in the baby [6]. Children born to mothers with
gestational diabetes have been reported to exhibit moreLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and lower intelligence quotient (IQ) scores and educational
attainment [7-9].
In adults, experimental studies where participants’ per-
formance on cognitive tests was evaluated after a meal
and a sugary drink, have shown that low plasma glucose
levels are associated with poorer results in memory and
attention tasks [10,11], as well as in non-memory tasks,
especially tasks that are more demanding [3]. Better cog-
nitive function was found to be dependent not only on a
higher baseline blood glucose concentration but also on
a tighter glucose control (i.e. the ability to keep glucose
levels within the normal range) [3]. Elevated glucose
levels such as those present in hyperglycaemia and dia-
betes have also been associated with diminished cogni-
tive function, accelerated cognitive decline and higher
risks for developing dementia and Alzheimer’s disease in
the elderly [12-14] although not all studies find this [15].
Observational epidemiological studies may be affected by
confounding, reverse causation and bias, which makes it
more problematic to infer causality [16]. In particular, asso-
ciations between nutritional status and cognitive ability will
be confounded by lifestyle and environmental factors.
Ideally, a randomized controlled trial (RCT) would be the
way to overcome this problem and obtain evidence for the
effects of a modifiable exposure, but, in this case, conduct-
ing an RCT would not be ethical. Therefore, we have
employed a Mendelian randomization strategy which uses
genetic variants that are reliably associated with a modifi-
able exposure (here, glucose levels) to make inferences
about the causal effect of this exposure on an outcome of
interest (i.e. IQ scores) [17]. Because genotypes are set ran-
domly at conception and are stable throughout life they are
unlikely to be affected by confounders that typically influ-
ence observational studies and similarly, will not be affected
by reverse causation and bias [17].
Candidate gene and more recently, genomewide asso-
ciation studies (GWAS) have identified a number of gen-
etic variants that are robustly associated with fasting
plasma glucose levels [18] and type 2 diabetes (T2D)
[19,20]. Together variants associated with fasting glucose
explain up to 5% of its genetic variance [21], whereas
those associated with T2D account for ~10% of the trait
variability [22]. We have genotyped 35 and 38 fasting
glucose/T2D-associated variants in the Avon Longitu-
dinal Study of Parents and Children (ALSPAC) mothers
and children, respectively, and used them to investigate
the relationship between glucose exposure and suscepti-
bility to T2D with child’s IQ at age 8. We examined the
association between fasting glucose and IQ using 16 of
these variants combined in a fasting glucose genetic risk
score (FGGRS) [21]. A type 2 diabetes genetic risk score
(T2DGRS) which includes 22 variants was also com-
puted to assess the relationship between T2D risk andIQ test results. The main objective of our study was to
establish whether glucose during gestation and child-




ALSPAC is a population-based prospective cohort study
investigating factors that affect the health and develop-
ment of children and their parents. The study methods
are described in detail elsewhere [23,24] (http://www.
alspac.bris.ac.uk). Briefly, pregnant women living around
Bristol, England, who had an expected date of delivery
between April 1991 and December 1992 were eligible,
and of these 14,541 were enrolled in the study. Extensive
data have been collected from the mothers and their off-
spring from pregnancy onwards by questionnaire, ab-
straction from medical notes, record linkage and by
attendance at research clinics. Ethical approval for the
study was obtained from the ALSPAC Law and Ethics
Committee (IRB# 00003312) and the Local Research
Ethics Committees (Bristol and Weston, Southmead,
and Frenchay Health Authorities). Written informed
consent was obtained from all participants in the study.
Numbers of mother-offspring pairs included in the
analyses are shown in Figure 1.
Assessment of offspring cognitive function
Cognitive testing was carried out by trained psycholo-
gists during a clinic visit when the children were aged 8
using a shortened version of the Wechsler Intelligence
Scale for Children (WISC-III) consisting of alternate
items only (except the coding task) [25]. An overall age
adjusted intelligence quotient (IQ) was derived from this
assessment for each child who completed the test [26].
Assessment of fasting glucose and glycosylated
hemoglobin (HbA1c) levels in children
From the population cohort a 10% randomly selected
sample of parents whose babies were born within the
last 6 months of the survey were invited to bring their
children to a research clinic (Children in Focus, CIF) at 4,
8 and 12 months of age and 6-monthly intervals thereafter,
where a number of clinical, physiological and psychological
assessments were carried out. Fasting glucose measure-
ments from children attending the CIF clinic were
obtained as part of the Before Breakfast Study done when
the children were ~8.5 years of age. Parental consent was
sought for venous blood samples, and was given for 81% of
the 1135 children in the CIF group. Blood samples were
taken after a minimum 6-hour fast. Plasma glucose was
measured using a glucose oxidase method implemented on
a Y.S.I. model 2300 STAT Plus analyser (Y.S.I., Lynchford
House, Farnborough, Hants, UK). Eight-hundred and
•339 women with more than one pregnancy in ALSPAC
•69 women with missing data
14,541 pregnant women recruited
•195 women with a multiple pregnancy14,133 women with only one pregnancy in ALSPAC
•340 non-white children, 1 miscarriage
13,938 women with singleton 
pregnancies
12,037 white women
•5424 children without IQ score11,696 white women with white 
children
•2501 mothers without genotype data (average)
•1194 children without genotype data (average)
6272 mother/child pairs 
with IQ score
3771 mothers with genotype data 
and child with IQ score (average)
5078 children with genotype data 
and IQ score (average)
•1,901 non-white women and women missing ethnicity data
Figure 1 Flow-diagram of participants in the study and reasons for exclusions.
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glucose, were included in our study.
At mean age 9 years, 7314 children attended the regular
research examination and blood was collected from all
children willing to provide a sample. HbA1c was mea-
sured from April 2002 to January 2003 from blood
obtained during the age 9 years examination using a
Menarini HA 8140 auto-analyser which employs a reverse
phase cation exchange HPLC with spectrophotometric de-
tection [27]. Results are expressed as a percentage of total
hemoglobin. HbA1c measurements were available for
1793 children, 1454 of whom were included in our study.
Assessment of diabetes categories in mothers
Data on pre-existing diabetes, gestational diabetes and
glycosuria was obtained for the index pregnancy from ante-
natal medical records as reported by Lawlor et al. (2010)
[28]. Glycosuria was defined as a measurement of at least
13.9 mmol/l or 250 mg/dl of plasma glucose on at least two
occasions at any time during the pregnancy [28]. Women
were classified into one of four mutually exclusive categor-
ies: no evidence of glycosuria or diabetes, existing diabetesbefore the pregnancy, gestational diabetes, and glycosuria.
A maternal diabetes/glycosuria variable was created and
coded as 0 (no diabetes) or 1 (pre-pregnancy diabetes/ges-
tational diabetes/glycosuria).
Potential confounders
Information on maternal education, social class, age at de-
livery, parity, interpregnancy interval, smoking, alcohol
consumption before and during pregnancy, and iron sup-
plementation was collected using questionnaires com-
pleted by the mothers at approximately 18 and 32 weeks of
pregnancy. Occurrence of any infection during pregnancy
was abstracted from medical records. Children’s date of
birth, sex, gestational age and birthweight were obtained
from birth records. Breastfeeding duration was recorded
from repeat postnatal questionnaires completed by the
mother and was categorized as no breastfeeding, breast-
feeding for < 3 months, for 3 to 5 months, for≥ 6 months.
Genetic variants
DNA was extracted as described previously [29]. Geno-
typing was undertaken by KBioscience Ltd. (www.
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lele specific PCR system (KASPar) for SNP analysis.
Thirty-five and 38 fasting glucose/T2D-associated SNPsTable 1 Genetic variants related to fasting glucose concentra




ADAMTS9 rs4607103 C/T 0.24
ADCY5 rs2877716 C/T 0.26
ADIPOQ rs1501299 G/T n/t
ADIPOQ rs17300539 G/A n/t
ADIPOQ rs266729 C/G n/t
ADRA2A rs10885122 G/T 0.13
C2CD4B rs11071657 A/G 0.39
CDC123/CAMK1D rs12779790 A/G 0.18
CDKAL1 rs10946398 A/C 0.31
CDKN2A/B rs10811661 T/C 0.18
COX2 rs20417 G/C 0.15
CRY2 rs11605924 C/A 0.48
DGKB/TMEM195 rs2191349 T/G 0.46
FADS1 rs174550 T/C 0.33
FTO rs9939609 T/A 0.40
G6PC2 rs560887 C/T 0.30
GCK rs1799884 G/A 0.18
GCKR rs780094 C/T 0.39
GLIS3 rs7034200 C/A 0.47
HHEX-IDE rs1111875 C/T 0.41
HNF1B rs757210 C/T 0.37
IGF2BP2 rs4402690 G/T 0.31
JAZF1 rs864745 A/G 0.50
KCNJ11 rs5219 C/T 0.35
KCNQ1 rs2237892 C/T 0.06
KCNQ1 rs2237895 A/C 0.42
MADD rs7944584 A/T 0.28
MTNR1B rs10830963 C/G 0.27
NOTCH2 rs10923931 G/T 0.11
PPARG rs1801282 C/G 0.12
PROX1 rs340874 C/T 0.43
SLC2A2 rs11920090 T/A 0.12
SLC30A8 rs13266634 C/T 0.30
TCF7L2 rs12255372 G/T 0.29
TCF7L2 rs7903146 C/T 0.30
THADA rs7578597 A/G 0.11
TSPAN8/LGR5 rs7961581 T/C 0.28
WFS1 rs10010131 G/A 0.40
MAF = minor allele frequency.
T2D = type 2 diabetes.
n/t = not typed.
*N = mean of the total number of individuals typed for each SNP. Range in mother
†minor allele frequency in the HapMap CEPH European population.
{risk allele for higher plasma fasting glucose or susceptibility to type 2 diabetes.were available for analysis in mothers and children, re-
spectively (Table 1). The top 10 principal components
(PCs) that reflect the population’s genetic structure weretion and type 2 diabetes examined in this study
MAF children
N=7685*
CEU† Risk allele{ Reported
associations
0.24 0.19 major T2D
0.26 0.25 major fasting glucose/T2D
0.27 0.27 minor T2D
0.09 0.08 minor T2D
0.26 0.31 minor T2D
0.12 0.10 major fasting glucose
0.38 0.41 major fasting glucose
0.19 0.22 minor T2D
0.31 0.30 minor T2D
0.17 0.20 major T2D
0.15 0.18 major T2D
0.48 0.54 minor fasting glucose
0.46 0.53 major fasting glucose/T2D
0.33 0.37 major fasting glucose
0.40 0.45 minor obesity
0.30 0.33 major fasting glucose
0.18 0.20 minor fasting glucose/T2D
0.39 0.38 major fasting glucose/T2D
0.48 0.53 minor fasting glucose
0.41 0.44 major T2D
0.37 0.43 minor T2D
0.30 0.29 minor T2D
0.50 0.48 major T2D
0.35 0.50 minor T2D
0.06 0.08 major T2D
0.41 0.36 minor T2D
0.28 0.29 major fasting glucose
0.28 0.30 minor fasting glucose/T2D
0.11 0.09 minor T2D
0.11 0.07 major T2D
0.43 0.44 major fasting glucose/T2D
0.13 0.13 major fasting glucose
0.30 0.25 major fasting glucose/T2D
0.29 0.22 minor fasting glucose
0.30 0.25 minor fasting glucose/T2D
0.11 0.08 major T2D
0.28 0.23 minor T2D
0.40 0.26 major T2D
s: 2553–7151. Range in children: 7295–8323.
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wide SNPs genotyped and imputed in ALSPAC mothers
and children using Markov Chain Haplotyping software
(MACH v.1.0) [31] and phased haplotype data from indi-
viduals of European ancestry (CEU) (Hapmap release 22,
Phase II NCBI B36, dbSNP 126), based on a cleaned
dataset of 8,340 mothers and 8,365 children and 464,311
autosomal SNPs. All 10 PCs were included as covariates
in the regression models to account for confounding by
population stratification.
Genetic risk scores
We computed a weighted fasting glucose genetic risk
score (FGGRS) as described by Barker et al. [21] using
16 genetic variants –out of the set of 35/38- that had
been reliably associated with fasting glucose levels in
prior studies [18]. Each SNP genotype was coded as 0, 1
or 2 depending on the number of risk alleles the individ-
ual carries, and their effects on fasting glucose levels in
adults were obtained from Barker et al. [21]. For each in-
dividual FGGRS was calculated as follows:
FGGRS= [(0.075*rs560887 + 0.067*rs10830963 + 0.062*
rs1799884 + 0.03*rs2191349 + 0.029*rs780094 + 0.027*rs2
877716 + 0.027*rs13266634 + 0.023*rs7903146 + 0.022*rs1
0885122 + 0.021*rs7944584 + 0.02*rs11920090 + 0.018*rs7
034200 + 0.017*rs174550 + 0.015*rs11605924 + 0.013*rs34
0874 + 0.008*rs11071657)/0.474]*16, where the denom-
inator corresponds to the total effect size (i.e. sum of all
SNP effects).
Two SNPs tested in this study were different from
those used by Barker et al., but they were located in the
same genes and were in strong linkage disequilibrium:
rs1799884 in GCK instead of rs4607517 (r2 = 1.0), and
rs2877716 in ADCY5 instead of rs11708067 (r2 = 0.8),
therefore the same effect was assumed.
Similarly, we calculated a type 2 diabetes genetic risk
score (T2DGRS) made up of the 22 variants from the
35/38 set that have been previously associated with the
disease. Excluded variants and reasons for their exclu-
sion were: all three SNPs in ADIPOQ because they had
been typed only in children, rs12779790 in CDC123/
CAMK1D had a considerably lower sample size in
mothers, and rs20417 in COX2 because its effects have
only been estimated in Pima Indians [32]. Eight SNPs
were common to both genetic scores. Effects for poly-
morphisms in the T2DGRS were obtained from Hivert
et al. [33] and the GWAS catalog. As with the FGGRS,
effects reported for rs917793 and rs11708067 were used
in place of those corresponding to the linked SNPs
rs1799884 and rs2877716. The effect of SNP rs2237895
was obtained from Unoki et al. (2008) [34]. The
T2DGRS was computed as:
T2DGRS= [(0.09*rs4607103 + 0.15*rs10946398 + 0.23*r
s10811661 + 0.16*rs1111875 + 0.1*rs757210 + 0.16*rs4402960 + 0.1*rs864745 + 0.15*rs5219 + 0.22*rs2237895 + 0.12*
rs10923931 + 0.17*rs1801282 + 0.14*rs7578597 + 0.09*rs7
961581 + 0.1*rs10010131 + 0.11*rs2877716 + 0.06*rs21913
49 + 0.07*rs1799884 + 0.06*rs780094 + 0.09*rs10830963 +
0.07*rs340874 + 0.14*rs13266634+ 0.31*rs7903146)/2.86]
*22.
In both FGGRS and T2DGRS, variants in strong linkage
disequilibrium with others already in the score were left
out as well (i.e. TCF7L2 rs12255372 and KCNQ1
rs2237892). From each pair of linked variants we selected
the variant with the greatest effect or if effects were simi-
lar, the best studied variant in European populations.
Statistical analysis
Maternal and offspring genotypes were checked for devi-
ation from Hardy-Weinberg equilibrium using the
hwsnp function implemented in the program Stata 11
(Stata Corporation, College Station, Texas). We investi-
gated the association of potential confounding factors
with exposures (i.e. fasting glucose and HbA1c concen-
trations, maternal diabetes/glycosuria, maternal and off-
spring genotypes and genetic risk scores) and outcome
(offspring IQ), as well as that of exposures and outcome
using linear regression and chi square tests as appropri-
ate. The association of offspring fasting glucose and
HbA1c levels with IQ was adjusted for child’s age and
sex, whereas that of maternal diabetes/glycosuria with
IQ was additionally adjusted for maternal age at delivery,
birthweight, gestational age and duration of breastfeed-
ing. As a child’s genotype may influence childhood
plasma fasting glucose, we controlled for it to specifically
assess the effect on IQ of maternal fasting glucose status
during pregnancy. Single variant analysis was performed
assuming an additive genetic model with the major allele
homozygote genotype as baseline. All analyses involving
genotypes or genetic risk scores and IQ were also
adjusted for the top 10 PCs as markers of population
stratification. The statistical package Stata 11 was used
to carry out all tests.
Results
WISC scores at age 8 were available for 6272 children
(49.9% of whom were male). The mean IQ score was
104.4 (SD, 16.4), assessed at 8 years 7 months (SD,
3.3 months) on average. The majority of ALSPAC
children exhibited fasting glucose and HbA1c levels
within the reference range (mean ± SD fasting glucose:
4.95 ± 0.39 mmol/l; mean ± SD HbA1c: 4.91 ± 0.31%).
According to the World Health Organization diabetes
mellitus is diagnosed when fasting plasma glucose is
≥7.0 mmol/l or HbA1c is ≥ 6.5% [35,36]. Three
ALSPAC children had fasting glucose levels compat-
ible with a diabetes diagnosis, the same was true for
HbA1c levels in two other children.
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lysis of genotype and IQ are shown in Figure 1. Table 1
lists all the genetic variants selected for the study, estab-
lishing whether they have been earlier associated with
fasting glucose or T2D or both.
Three SNPs in the mothers (rs10923931, rs757210,
rs340874) and two in the children (rs757210, rs340874)
were out of Hardy-Weinberg equilibrium (p≤ 0.02) al-
though this is not the case if a Bonferroni correction for
multiple testing is applied. These SNPs were not
excluded from the analysis. Allele frequencies for these
variants were similar to those reported for the HapMap
CEU population (Table 1).
Confounders
Offspring IQ was associated with 13 out of 15 (87%) of the
covariables considered here at a nominal p-value threshold
of 0.05. Fasting glucose in children was associated with sex,
with girls showing lower levels of plasma fasting glucose
than boys (mean±SD: 4.88±0.38 vs 5.01± 0.40). Both fast-
ing glucose and HbA1c were associated with duration of
breastfeeding. Children breastfed for three months or less
exhibited the highest mean difference in fasting glucose
(0.07 mmol/l; 95% CI −0.02, 0.15) and HbA1c (0.10%; 95%
CI 0.05, 0.15) levels with respect to never breastfed chil-
dren. Maternal diabetes/glycosuria was strongly associated
with gestational age (mean difference in gestational age be-
tween diabetic and non-diabetic mothers: -0.28 weeks; 95%
CI −0.45, -0.12), birthweight (mean difference in child’s
birthweight between diabetic and non-diabetic mothers:
96.5 g; 95% CI 45.7, 147.2) and duration of breastfeeding
(34% of diabetic mothers never breastfed compared to 25%
of non-diabetic mothers).
In children, 29 associations of genotype with confoun-
ders were expected below a nominal p-value of 0.05 in a
total of 570 tests (15 confounders x 38 SNPs) and 43
(7.5%) were observed. Whereas among mothers 26 asso-
ciations were expected and 28 (5.3%) were found in 525
tests (15 confounders x 35 SNPs). Both maternal risk
scores were associated with gestational age, and T2DGRS
was also associated with child’s sex. Offspring FGGRS and
T2DGRS were both associated with interpregnancy inter-
val and alcohol intake. Whereas FGGRS was alsoTable 2 Mean difference in fasting glucose and HbA1c levels
Genetic risk score N Fasting glucose (mmol/l)
FGGRS 573 0.02 (0.01, 0.03)
T2DGRS 511 0.003 (−0.01, 0.01)
N HbA1c (%)
FGGRS 1037 0.02 (0.01, 0.02)
T2DGRS 918 0.004 (−0.002, 0.01)
FGGRS = fasting glucose genetic risk score.
T2DGRS = type 2 diabetes genetic risk score.
PCs = population stratification principal components.associated with taking iron supplementation during preg-
nancy, and T2DGRS was associated with smoking and
maternal age at delivery as well (data available on request).
However, the associations of genetic variants and scores
with confounders were not strong enough to overcome a
Bonferroni correction for multiple testing.
In summary, while we detected strong associations of
confounders with the outcome (i.e. IQ) and exposures
(i.e. fasting glucose and HbA1c levels, maternal diabetes/
glycosuria) of interest, that was not the case with the
genetic variants and scores.
Association of SNPs and genetic risk scores with fasting
glucose and HbA1c levels in children
The offspring FGGRS followed a normal distribution, with
a mean score of 17.1 and a range between 6.5 and 26.9. It
was strongly and positively associated with offspring fast-
ing glucose and HbA1c levels, explaining 2-3% of trait
variance, which indicates that it may be able to tell us
something about the effect of glucose on outcome
(Table 2). Adjustment for population stratification did not
alter the estimated effect (Table 2).
Likewise, the T2DGRS in children was distributed nor-
mally, with a mean of 22.6 (range: 8.9-33.9). No associ-
ation was detected with fasting glucose and HbA1c
plasma concentrations (Table 2).
Individual SNPs in the genes ADCY5, G6PC2, GCK
and HNF1B were associated with fasting glucose levels
(see Additional file 1: Table S1). With the exception of
rs757210 in HNF1B, which has been linked only to T2D,
the remaining three SNPs had been previously asso-
ciated with fasting glucose [18]. Individual SNPs asso-
ciated with HbA1c were located in MTNR1B, SLC2A2,
G6PC2, WFS1 and GCKR. All variants were reported to
be associated with fasting glucose although rs10010131
in WFS1 was associated with fasting glucose and HbA1c
levels only among individuals who developed hypergly-
caemia or T2D [18,37] (see Additional file 2: Table S2).
Association of SNPs and genetic risk scores with maternal
diabetes/glycosuria
We did not have fasting glucose and HbA1c plasma
levels in pregnancy for the mothers to perform a similarper weighted allele of genetic risk score in children
p-value N Adjusted by PCs p-value
7.1x10-5 522 0.02 (0.01, 0.03) 0.001
0.59 467 0.003 (−0.01, 0.01) 0.61
p-value N Adjusted by PCs p-value
1.6x10-6 933 0.02 (0.01, 0.02) 1.4x10-5
0.20 831 0.005 (−0.002, 0.01) 0.19
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ited statistical power, we did explore the association of
maternal genetic risk scores and single variants with the
maternal diabetes/glycosuria phenotype. The FGGRS
was not associated with this variable but the T2DGRS
showed a marginal association (mean difference in
T2DGRS between diabetic and non-diabetic mothers:
0.48; 95% CI, -0.01, 0.98; p = 0.06). When SNPs were
tested individually we found evidence of association with
rs7903146 in TCF7L2 and rs10830963 in MTNR1B.
Association of fasting glucose concentration, HbA1c
fraction, SNPs and genetic risk scores with IQ in children
Fasting glucose was inversely associated with IQ scores
although the effect was small and imprecisely estimated.
HbA1c levels were not associated with IQ. The FGGRS
also appeared to be inversely associated with IQ but
again this is not distinguishable from the null hypothesis.
Equally, no association was found between the T2DGRS
and child’s IQ (Table 3).
When variants were analyzed independently, associations
between SNPs rs10811661 in CDKN2A/2B, rs1801282 in
PPARG and rs7961581 in TSPAN8-LGR5, and IQ were
identified (see Additional file 3: Table S3). After adjustment
for population stratification SNPs rs10811661, rs1801282,
rs20417 in COX2, rs2237892 in KCNQ1 show evidence for
association with IQ (see Additional file 4: Table S4). These
variants have been previously related to T2D risk but not
to fasting glucose (Table 1) [19,20,32,38]. In the first two
cases the allele that increases risk for developing T2D was
associated with a higher IQ score while the opposite was
true for COX2 and KCNQ1.
Association of maternal SNPs and genetic risk scores with
offspring IQ
Maternal FGGRS was normally distributed, with a mean
score of 17.1 and a range between 6.8 and 27.6. There was
no evidence of an association with offpring IQ (Table 4).
The maternal T2DGRS exhibited a normal distribution
with mean 22.6 and a range between 10.9 and 34.7, but,
unlike the FGGRS, there was some evidence that it wasTable 3 Association of children’s fasting glucose, HbA1c level
Exposure N (unadjusted/adjusted) Mean diffe
per unit change in
fasting glucose (mmol/l) 784/784 −1.94 (−
HbA1c (%) 1198/1198 0.43 (−
Genetic risk score N (unadjusted/adjusted) Mean diffe
per weighted
FGGRS 3904/3457 −0.09 (−
T2DGRS 3468/3053 0.01 (−
FGGRS = fasting glucose genetic risk score.
T2DGRS = type 2 diabetes genetic risk score.
PCs = population stratification principal components.positively associated with offspring IQ after adjustment
for child’s T2DGRS and population stratification (Table 4).
In the single variant analysis, SNPs rs7034200 in GLIS3,
rs864745 in JAZF1 and rs340874 in PROX1 were
associated with child’s IQ (see Additional file 5: Table S5).
Adjustment for offspring genotype and population stratifi-
cation showed additional associations of rs560887 in
G6PC2 and rs10010131 in WFS1, but the association
with GLIS3 was no longer evident (see Additional file 6:
Table S6). In JAZF1 and G6PC2 the allele associated with
susceptibility to T2D or higher plasma fasting glucose was
associated with a higher IQ, whilst in PROX1 and WFS1
the risk allele appeared to reduce IQ.
Association of maternal diabetes/glycosuria with
offpring IQ
Offspring of mothers with diabetes/glycosuria exhibited a
lower IQ score than children born to non-diabetic mothers
(mean difference in offspring IQ between diabetic and non-
diabetic mothers: -3.5, 95% CI −5.6, -1.5; p =0.001; with ad-
justment for child’s age and sex, maternal age at delivery,
birthweight, gestational age and duration of breastfeeding).
Discussion
We have confirmed that a FGGRS is strongly associated
with fasting glucose in a population based cohort and
therefore may be used to determine the effect of glucose
exposure on a phenotype of interest. It was not only
strongly associated with fasting glucose levels but also
with levels of HbA1c [39]. Not all SNPs reported to be
associated with fasting glucose [18] showed an association
with this exposure in our analysis but three of the variants
with the strongest effects in earlier studies did (i.e. those in
ADCY5, G6PC2 and GCK). Genes associated with HbA1c
in our study include two described in a previous GWAS of
HbA1c (MTNR1B and G6PC2), although the variants
examined were different [39], and a SNP inWFS reportedly
linked to HbA1c in a prospective epidemiological study
conducted in France [37].
The T2DGRS, including all variants associated with T2D,
some of which were also associated with fasting glucose,s, and genetic risk scores, with IQ at age 8
rence in IQ
exposure (95% CI)
p-value Adjusted by child’s age
and sex
p-value
4.71, 0.82) 0.17 −2.22 (−5.01, 0.56) 0.12
2.53, 3.40) 0.78 0.65 (−2.29, 3.59) 0.67
rence in IQ
allele (95% CI)
p-value Adjusted by PCs p-value
0.26, 0.08) 0.29 −0.11 (−0.30, 0.07) 0.22
0.15, 0.18) 0.87 0.06 (−0.12, 0.24) 0.52
Table 4 Association of maternal genetic risk scores with offspring IQ at age 8
Genetic risk score N (unadjusted/adjusted) Mean difference in IQ
per weighted allele (95% CI)
p-value Adjusted by offspring
score and PCs
p-value
FGGRS 2732/1374 −0.03 (−0.24, 0.17) 0.74 0.20 (−0.14, 0.53) 0.26
T2DGRS 2423/1102 0.16 (−0.04, 0.36) 0.12 0.47 (0.12, 0.81) 0.01
FGGRS = fasting glucose genetic risk score.
T2DGRS = type 2 diabetes genetic risk score.
PCs = population stratification principal components.
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Neither were the maternal and the offspring FGGRS nor
the offspring T2DGRS associated with IQ in the ALSPAC
population. In contrast, the maternal T2DGRS was asso-
ciated with an increase of 0.03SD in child’s IQ after adjust-
ment for offspring T2DGRS and population stratification.
Additionally, we uncovered associations with IQ for a
few individual SNPs in mothers and children, the major-
ity of which were T2D but not fasting glucose-associated
variants. Only the variants in PROX1 and G6PC2 had
been associated with levels of fasting glucose before
[18,40]. Since there was some indication that the PROX1
SNP was in HW disequilibrium in mothers and children
this association should be carefully assessed. However,
evidence for the association of IQ with individual var-
iants disappears after a Bonferroni correction for mul-
tiple testing (cut-off p-value: 0.001).
We did not detect an association of the FGGRS with
diabetes/glycosuria in the mothers, yet this outcome was
positively associated with the T2DGRS. SNPs independ-
ently associated with maternal diabetes/glycosuria had
been earlier related to plasma fasting glucose regulation
and T2D risk.
Overall, there was very little overlap between the SNPs
associated with fasting glucose and HbA1c levels, mater-
nal diabetes/glycosuria and IQ scores in ALSPAC.
Given the results described above, we have not found
sufficient evidence that fasting glucose concentration ei-
ther in mothers during gestation or in children later in
life affects cognitive ability at mean age 8, but we lacked
statistical power to reliably establish the absence of asso-
ciation. Despite the FGGRS being strongly associated
with fasting glucose in plasma its effects are quite small
therefore a larger sample size will be required to carry
out an adequately powered analysis.
On the other hand, we have uncovered some evidence
that children of mothers who carry T2D susceptibility
alleles exhibit higher IQ scores than children of non-car-
riers. This appears to be in disagreement with recent
studies, and our study as well, that have revealed that
maternal pre-pregnancy diabetes and gestational dia-
betes, especially with poor metabolic control, have an
adverse effect on offspring cognition [9,41,42], although
not all studies have detected a reduction in IQ scores
[43,44]. We speculate that the presence of T2D riskalleles (which could be contributing to maintain higher
glucose levels in blood) may be beneficial during preg-
nancy as women have to fulfil the baby’s glucose require-
ments besides their own. However, having a fully
established disease phenotype, such as gestational dia-
betes, can in turn be detrimental, either because glucose
levels end up being excessively high or because of the
existence of factors related to the disease, other than
hyperglycemia, that unfavourably influence neurodeve-
lopment and are not captured by these genetic variants
and scores. Additionally, the negative association be-
tween diabetes and cognition could be the result of con-
founding by lifestyle and other factors such as poor diet,
smoking, alcohol intake and a lower educational achieve-
ment. Further studies are definitely needed to examine
this issue in greater detail.
Strengths and limitations
Among the strengths of our study is having access to a
large birth cohort such as ALSPAC to explore the role of
maternal fasting glucose status during pregnancy and their
offspring own fasting glucose levels in relation to cognitive
ability in children. Then, the validation in the ALSPAC
population of a robust instrument such as the FGGRS,
which can be used in future Mendelian randomization
studies to determine the causal relationship between fast-
ing glucose (or HbA1c) levels and specific phenotypes.
Lack of power to obtain conclusive results is likely the
major weakness of this study. Additionally, because most
individuals had fasting glucose and HbA1c levels within
the normal range, it may have not been possible in this set-
ting to unravel an association that manifests itself only
under very high or very low glucose concentrations.
Conclusions
Based on our results we conclude that genetic variants
associated with subtle variations in fasting glucose levels
do not have an important influence on IQ. However,
additional studies in larger cohorts should be carried out
to confirm these findings.
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